The upcoming bankruptcy hearing on February 18, 2025, will be crucial in determining whether Johnson & Johnson’s proposed $10 billion bankruptcy plan can move forward. The company is using a controversial legal strategy called the Texas two-step, which aims to limit its liability for cancer claims while protecting its financial interests.
Some victims support this approach for quicker compensation, while others argue it unfairly prioritizes the company’s needs over justice for those harmed. The hearing follows a significant Supreme Court ruling in Purdue Pharma’s bankruptcy, which could impact the legality of J&J’s plan. This case may lead to justice for many victims or result in further delays, with appeals potentially extending the legal battle.
[fluentform id=”15″]
